Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWorkspace Regulatory News (WKP)

Share Price Information for Workspace (WKP)

Share Price is delayed by 15 minutes
Get Live Data
340.00    1.00 (0.29%)
Bid:
340.00
Ask:
340.80
Spread: 0.80 (0.235%)
Market Cap: £653.78m
WKP Live PriceLast checked at - London Stock Exchange

Intraday Workspace Share Chart

Form 8.3 - Workspace Group PLC

10 Mar 2022 13:12

Cohen & Steers Capital Management - Form 8.3 - Workspace Group PLC

Cohen & Steers Capital Management - Form 8.3 - Workspace Group PLC

PR Newswire

London, March 10

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Cohen & Steers, Inc.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeWorkspace Group plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure9 March 2022
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:GBP1ORDINARY
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:7,945,2304.39
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:7,945,2304.39

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:N/A
Details, including nature of the rights concerned and relevant percentages:N/A

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
GBP1ORDINARYPurchase3,4566.08 GBP
GBP1ORDINARYPurchase186.14 GBP
GBP1ORDINARYSale320,0006.09 GBP

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:March 10, 2022
Contact name:Anthony Puma
Telephone number*:+1 212-446-9163

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
22nd Mar 201811:41 amRNSHolding(s) in Company
22nd Mar 20187:00 amRNSPlanning Consent
16th Mar 20182:22 pmRNSVoting Rights and Share Capital
16th Mar 201811:18 amRNSHolding(s) in Company
19th Feb 20182:01 pmRNSHolding(s) in Company
19th Feb 201811:57 amRNSDirector/PDMR Shareholding
30th Jan 201811:36 amRNSDirector Declaration
22nd Jan 20187:00 amRNSAcquisition
18th Jan 20187:00 amRNSThird Quarter Business Update
9th Jan 201810:12 amRNSVoting Rights and Share Capital
9th Jan 201810:12 amRNSVoting Rights and Share Capital
20th Nov 20175:23 pmRNSBlocklisting Application
9th Nov 20179:53 amRNSVoting Rights and Share Capital
8th Nov 20177:00 amRNSHalf Year Results
31st Oct 20174:32 pmRNSHolding(s) in Company
24th Oct 20175:32 pmRNSHolding(s) in Company
26th Sep 20175:04 pmRNSVoting Rights and Share Capital
11th Sep 20175:22 pmRNSVoting Rights and Share Capital
11th Sep 20175:04 pmRNSHolding(s) in Company
11th Sep 20179:37 amRNSDisposal
7th Sep 20172:44 pmRNSDirector/PDMR Shareholding
4th Sep 20172:22 pmRNSDirector/PDMR Shareholding
31st Aug 20175:56 pmRNSDirector/PDMR Shareholding
30th Aug 20177:00 amRNSDisposal
21st Aug 201711:19 amRNSCompletion of £200m Private Placement
17th Aug 201712:06 pmRNSHolding(s) in Company
2nd Aug 201710:29 amRNSDirector/PDMR Shareholding
28th Jul 20177:00 amRNSPrivate Placement of £200m
26th Jul 20172:35 pmRNSDirector/PDMR Shareholding
20th Jul 20172:23 pmRNSDirector/PDMR Shareholding
14th Jul 201711:09 amRNSResult of AGM
14th Jul 20177:00 amRNSFirst Quarter Business Update
5th Jul 201710:21 amRNSVoting Rights and Share Capital
30th Jun 201710:40 amRNSDirector/PDMR Shareholding
28th Jun 20174:17 pmRNSDirector/PDMR Shareholding
28th Jun 201710:24 amRNSDirector/PDMR Shareholding
23rd Jun 20177:00 amRNSAcquisition
19th Jun 20177:00 amRNSDisposal
14th Jun 20174:03 pmRNSAnnual Report and Notice of AGM
8th Jun 20177:00 amRNSResponse to media speculation
7th Jun 20177:00 amRNSFinal Results
17th May 20177:00 amRNSDisposal
13th Apr 20174:58 pmRNSBlocklisting Application
13th Apr 20172:48 pmRNSVoting Rights and Share Capital
29th Mar 20177:00 amRNSAcquisition
28th Mar 20173:18 pmRNSDirector/PDMR Shareholding
28th Feb 20171:12 pmRNSDirector Declaration
28th Feb 20177:00 amRNSCAPITAL MARKETS EVENT
24th Feb 20177:00 amRNSAcquisition
20th Feb 20173:20 pmRNSVoting Rights and Share Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.